¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Receptor, IGF Type 2"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
asthenic type
¹«·ÂüÇü
blood type
Ç÷¾×Çü
Borrmann type
º¸¸£¸¸Çü
Cowdry type A inclusion bodies
Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
Cowdry type B inclusion bodies
Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
delayed-type hypersensitivity
Áö¿¬°ú¹Î(¼º)
disorganized type schizophrenia
ºØ±«ÇüÁ¤½ÅºÐ¿º´
extroverted feeling type
¿ÜÇâÀû°¨Á¤Çü
extroverted type
¿ÜÇâÇü
enteropathy-type T-cell lymphoma
À庴ÁõÇüT¼¼Æ÷¸²ÇÁÁ¾
Golgi type I neuron
±äÃà»è½Å°æ¼¼Æ÷, °ñÁö1Çü½Å°æ¼¼Æ÷
Golgi type II neuron
ªÀºÃà»è½Å°æ¼¼Æ÷, °ñÁö2Çü½Å°æ¼¼Æ÷
hyperlipidemia type I
1Çü°íÁöÇ÷Áõ
hyperlipidemia type IV
4Çü°íÁöÇ÷Áõ
hyperlipidemia type V
5Çü°íÁöÇ÷Áõ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
receptor binding
¼ö¿ëü°áÇÕ
receptor
¼ö¿ëü, ¼ö¿ë±â
antigen receptor
Ç׿ø¼ö¿ëü
opiate receptor
¾ÆÆí¼ö¿ëü
sensory receptor
°¨°¢¼ö¿ëü
receptor site
¼ö¿ëüºÎÀ§
tension type headache
±äÀåÇüµÎÅë
storage-type
ÃàÀûÇü
type
Çü, À¯Çü
blood type
Ç÷¾×Çü
Borrmann type
º¸¸£¸¸Çü
cellular type
¼¼Æ÷Çü
lepromatous type
³ªÁ¾Çü
scirrhous type
°æÈÇü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
abortive type
ºÎÀüÇü
anovulatory type
¹«¹è¶õÇü
asthenic type
¹«·ÂüÇü
athletic type
°ÇÀåÇü
precision type attachment
Á¤¹ÐÇüºÎÂø
type specific antigen
ÇüƯÀÌÇ׿ø
blood type
Ç÷¾×Çü
bubble type vaporizer
±âÆ÷Çü±âȱâ
cellular type
¼¼Æ÷Çü
culture type
Ç¥ÁرÕÁÖ, ±âÁØÁÖ
linear type constitution
¼±ÇüüÇü
swaged cast type crown
¾ÐÀÎÇü±Ý°ü
type culture
Ç¥ÁرÕÁ¾
type culture collection
Ç¥ÁرÕÁÖ¼ö·Ï
delayed-type hypersensitivity
Áö¿¬°ú¹Î
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
IGF-I
¸é¿ª±Û·ÎºóF-I
IGF-I(insulin-like growth factor-I)
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
IGF-II
¸é¿ª±Û·ÎºóF-II
A1 receptor
A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
A2 receptor
A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
CR1 => complement receptor 1
º¸Ã¼¼ö¿ëü 1
CR2 => complement receptor 2
º¸Ã¼¼ö¿ëü 2
CR3 => complement receptor 3
º¸Ã¼¼ö¿ëü 3
CR4 => complement receptor 4
º¸Ã¼¼ö¿ëü 4
Gustatory receptor
¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
H2 receptor antagonist
H2 ¼ö¿ëü ±æÇ×Á¦µé
Ig receptor
¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
Internalization, receptor
³»È(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
Kainate amino acid receptor
Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
Kinesthetic receptor
¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
adrenergic receptor
¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â,°¨¼öü)
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
³²¼ºÈ£¸£¸ó ¼ö¿ëü
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü.
benzodiazepine receptor agonists(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ÀÛ¿ëÁ¦
benzodiazepine receptor antagonist(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ±æÇ×Á¦
benzodiazepine receptor(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü
beta adrenergic receptor
º£Å¸¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼öü)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½